Listed

Vaxart, Inc.

VXRTOTCCIK 72444HealthcareFiscal year ends Dec 31

Reports and events: 453 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Vaxart, Inc., Reports and events
FiledFormWhat it isAccession number
2023-07-1016:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-23-019649
2023-06-2816:22 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001437749-23-018762
2023-06-0816:27 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-23-016984
2023-06-0608:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-23-016683
2023-05-2516:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-23-015869
2023-05-0916:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-23-013335
2023-05-0416:05 ET10-QQuarterly reportPeriod 2023-03-310001437749-23-012560
2023-04-2816:20 ETDEF 14AProxy statementPeriod 2023-06-260001437749-23-011635
2023-03-3108:30 ET8-K3.01 Delisting notice0001437749-23-008704
2023-03-1619:58 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-23-006768
2023-03-1516:01 ET10-KAnnual reportPeriod 2022-12-310001437749-23-006688
2022-12-1917:25 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-029381
2022-12-0616:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-22-028549
2022-11-0918:04 ET10-QQuarterly reportPeriod 2022-09-300001437749-22-026427
2022-11-0816:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-22-026356
2022-09-0107:05 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-22-021620
2022-08-2516:09 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-021345
2022-08-0817:27 ET10-QQuarterly reportPeriod 2022-06-300001437749-22-019415
2022-08-0816:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-22-019360
2022-08-0508:02 ET8-K/A5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-019024
2022-07-2808:00 ET8-K8.01 Other events0001437749-22-017950
2022-07-0816:16 ET8-K5.07 Shareholder vote results0001437749-22-016900
2022-07-0616:02 ET8-K1.01 Entry into a material agreement0001437749-22-016719
2022-06-2817:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-22-016094
2022-06-1616:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-22-015164
2022-06-0816:06 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-22-014593
2022-06-0616:03 ET8-K8.01 Other events0001437749-22-014390
2022-05-1117:27 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-22-011958
2022-05-1017:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-22-011555
2022-05-0917:30 ET10-QQuarterly reportPeriod 2022-03-310001437749-22-011554
2022-04-2816:04 ETDEF 14AProxy statementPeriod 2022-06-070001437749-22-010078
2022-03-3116:11 ET8-K5.02 Departure or appointment of officers or directors0001437749-22-007861
2022-02-2416:48 ET10-KAnnual reportPeriod 2021-12-310001437749-22-004354
2022-02-2416:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-22-004328
2022-02-1516:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-22-003408
2021-12-0116:00 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-21-027619
2021-11-0416:09 ET10-QQuarterly reportPeriod 2021-09-300001437749-21-025287
2021-11-0416:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-21-025286
2021-09-2116:18 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-21-022493
2021-09-1614:42 ET8-K/A1.01 Entry into a material agreement0001437749-21-022254
2021-09-1621:47 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001437749-21-022233
2021-08-2316:23 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-21-020715
2021-08-0516:22 ET10-QQuarterly reportPeriod 2021-06-300001437749-21-018764
2021-08-0516:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-21-018751
2021-08-0216:11 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-21-018143
2021-07-2018:42 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001437749-21-017163
2021-07-0916:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-21-016718
2021-06-2116:03 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001437749-21-015258
2021-05-0616:03 ET10-QQuarterly reportPeriod 2021-03-310001437749-21-011133
2021-05-0313:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001437749-21-010590

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.